[1]
O. Dembele, “Risk-Based Post-Marketing Surveillance (RB-PMS) of antimalarial drugs and maternal, neonatal and reproductive health (MNCH) in Mali”, J. Drug Delivery Ther., vol. 12, no. 2, pp. 6–10, Mar. 2022, doi: 10.22270/jddt.v12i2.5223.